Læknablaðið - 15.02.1993, Blaðsíða 43

LÆKNABLAÐIÐ
85
7. Muller DWM, Topol EJ. Selection of Patients with
Acute Myocardial Infarction for Thrombolytic
Therapy. Ann Intem Med 1990; 113: 949-60.
8. Blankenship JC, Almquist AK. Cardiovascular
complications of thrombolytic therapy in patients with
a mistaken diagnosis of acute myocardial infarction. J
Am Coll Cardiol 1989; 14; 1579-82.
9. ISIS-2 colloborative group. Randomized trial of
intravenous streptokinase, oral aspirin, both or neither
among 17187 cases of suspected acute myocardial
infarction: ISIS-2. Lancet 1988; 332: 349-60.
10. Kennedy JW. Expanding the use of thrombolytic
therapy for acute myocardial infarction. Ann Intem
Med 1990; 113: 907-8.
11. Beek AM, Verheugt FWA, Meyer A. Usefulness
of electrocardiographic findings and creatin kinase
levels on admission in predicting the accuracy of
the interval between onset of chest pain of acute
myocardial infarction and initiation of thrombolytic
therapy. Am J Cardiol 1991; 68: 1287-90.
12. The ISAM study group, et al. Serial Evaluation
of Left Ventricular Function Up to 3 Years
After Infarction Estimated by Radionuclide
Ventriculography. J Am Coll Cardiol 1991; 18: 1610-
6.
13. Mauri F, Gasparini M. Barbonaglia L, et al.
Prognostic significance of the extent of myocardial
injury in acute myocardial infarction treated by
streptokinase (the GISSI trial). Am J Cardiol 1989;
63: 1291-5.
14. O’Connor CM, Califf RM. Aggressive therapy of
acute M.I. in the elderly. Hospital Practice 1992; 27:
59-62, 66, 69.
15. Healy B. The Yentl syndrome. N Engl J Med 1991;
325: 274-6.
16. Steingart RM, Packer M. Hamm P, et al: Sex
differences in the management of coronary artery
disease. N Engl J Med 1991; 325: 226-30.
17. The consensus II study group. Effects of the early
administration of enalapril on mortality in patients
with acule myocardial infarction. N Engl J Med 1992;
327: 678-84.